Quote: "Generic manufacturers in USA say they expect deflation will contnue, and are worried that lower prices could put pressure on profits and threaten the viability of the companies. This could lead to a wave of mergers and acquisitions, reducing competition and leading to higher prices"
I think in worse scenario and after continuing 2-3 years downturn, Mayne Pharma will sell their generic business too ...
Fundamentals Are Strong, page-851
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.95 |
Change
0.000(0.00%) |
Mkt cap ! $333.4M | |||
| Open | High | Low | Value | Volume |
| $3.96 | $3.96 | $3.89 | $257.7K | 65.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 216 | $3.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.96 | 2164 | 18 |
View Market Depth
| Last trade - 12.01pm 07/08/2024 (20 minute delay) ? |
| MYX (ASX) Chart |